Clinical trial
Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
NCT01849159 is registered in ClinicalTrials.gov with Federal Research Clinical Center of Federal Medical & Biological Agency, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
- Lead sponsor
- Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- March 31, 2014
- Completion date
- June 30, 2017
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.